Hundhausen N, Majumder S, Xiao Y, Haeusl S, Goehler H, Seal R
iScience. 2025; 28(2):111937.
PMID: 40028277
PMC: 11872454.
DOI: 10.1016/j.isci.2025.111937.
van Pul L, Stunnenberg M, Kroeze S, van Dort K, Boeser-Nunnink B, Harskamp A
PLoS One. 2024; 19(10):e0298472.
PMID: 39356699
PMC: 11446443.
DOI: 10.1371/journal.pone.0298472.
Han S, Georgiev P, Ringel A, Sharpe A, Haigis M
Cell Metab. 2022; 35(1):36-55.
PMID: 36473467
PMC: 10799654.
DOI: 10.1016/j.cmet.2022.11.005.
Watanabe N, Mo F, McKenna M
Front Immunol. 2022; 13:876339.
PMID: 35493513
PMC: 9043864.
DOI: 10.3389/fimmu.2022.876339.
Smith C, Snyder C
Front Immunol. 2021; 12:704862.
PMID: 34335618
PMC: 8320728.
DOI: 10.3389/fimmu.2021.704862.
Antigenic Restimulation of Virus-Specific Memory CD8 T Cells Requires Days of Lytic Protein Accumulation for Maximal Cytotoxic Capacity.
Migueles S, Rogan D, Gavil N, Kelly E, Toulmin S, Wang L
J Virol. 2020; 94(23).
PMID: 32907983
PMC: 7654275.
DOI: 10.1128/JVI.01595-20.
The Immune Response Against Human Cytomegalovirus Links Cellular to Systemic Senescence.
Heath J, Grant M
Cells. 2020; 9(3).
PMID: 32245117
PMC: 7140628.
DOI: 10.3390/cells9030766.
From Vaccine Vector to Oncomodulation: Understanding the Complex Interplay between CMV and Cancer.
Wilski N, Snyder C
Vaccines (Basel). 2019; 7(3).
PMID: 31323930
PMC: 6789822.
DOI: 10.3390/vaccines7030062.
The Cytomegalovirus-Specific IL-21 ELISpot Correlates with Allograft Function of Kidney Transplant Recipients.
Lindemann M, Korth J, Sun M, Xu S, Struve C, Werner K
Int J Mol Sci. 2018; 19(12).
PMID: 30544783
PMC: 6320857.
DOI: 10.3390/ijms19123945.
An Early Immediate Early Protein IE-1-Specific T-Cell Polyfunctionality Is Associated With a Better Control of Cytomegalovirus Reactivation in Kidney Transplantation.
Dekeyser M, Ladriere M, Audonnet S, Frimat L, Bittencourt M
Kidney Int Rep. 2017; 2(3):486-492.
PMID: 29142976
PMC: 5678683.
DOI: 10.1016/j.ekir.2017.02.016.
TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1.
Sabins N, Chornoguz O, Leander K, Kaplan F, Carter R, Kinder M
J Immunol. 2017; 199(12):4091-4102.
PMID: 29127145
PMC: 5713500.
DOI: 10.4049/jimmunol.1701030.
Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation.
Nada M, Wang H, Workalemahu G, Tanaka Y, Morita C
J Immunother Cancer. 2017; 5:9.
PMID: 28239463
PMC: 5319075.
DOI: 10.1186/s40425-017-0209-6.
γδ T Cell-Mediated Immunity to Cytomegalovirus Infection.
Khairallah C, Dechanet-Merville J, Capone M
Front Immunol. 2017; 8:105.
PMID: 28232834
PMC: 5298998.
DOI: 10.3389/fimmu.2017.00105.
Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells.
van Aalderen M, Remmerswaal E, Heutinck K, Ten Brinke A, Feltkamp M, van der Weerd N
PLoS Pathog. 2016; 12(10):e1005903.
PMID: 27723787
PMC: 5056763.
DOI: 10.1371/journal.ppat.1005903.
Human cytomegalovirus pUL10 interacts with leukocytes and impairs TCR-mediated T-cell activation.
Bruno L, Cortese M, Monda G, Gentile M, Calo S, Schiavetti F
Immunol Cell Biol. 2016; 94(9):849-860.
PMID: 27192938
DOI: 10.1038/icb.2016.49.
Infection history determines the differentiation state of human CD8+ T cells.
van Aalderen M, Remmerswaal E, Verstegen N, Hombrink P, Ten Brinke A, Pircher H
J Virol. 2015; 89(9):5110-23.
PMID: 25717102
PMC: 4403462.
DOI: 10.1128/JVI.03478-14.
Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.
Quinn M, Turula H, Tandon M, Deslouches B, Moghbeli T, Snyder C
J Immunol. 2015; 194(4):1726-1736.
PMID: 25595792
PMC: 4684174.
DOI: 10.4049/jimmunol.1402757.
Immunity to viruses: learning from successful human vaccines.
Pulendran B, Oh J, Nakaya H, Ravindran R, Kazmin D
Immunol Rev. 2013; 255(1):243-55.
PMID: 23947360
PMC: 3748616.
DOI: 10.1111/imr.12099.
High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control.
Akulian J, Pipeling M, John E, Orens J, Lechtzin N, McDyer J
Am J Transplant. 2012; 13(1):146-56.
PMID: 23016698
PMC: 3827914.
DOI: 10.1111/j.1600-6143.2012.04282.x.
Cytomegalovirus-induced effector T cells cause endothelial cell damage.
van de Berg P, Yong S, Remmerswaal E, van Lier R, Ten Berge I
Clin Vaccine Immunol. 2012; 19(5):772-9.
PMID: 22398244
PMC: 3346330.
DOI: 10.1128/CVI.00011-12.